From Medscape Diabetes & Endocrinology

Coverage from the

ObesityWeek® 2020

November 02 - 05, 2020; Virtual

November 02 - 05, 2020 Virtual
  • Obesity Week 2020 New Drug Looks Good for Rare Genetic Severe Obesity 'The impact of setmelanotide in the obesity clinic is likely to increase in genetic screening to identify a subset of patients that can benefit,' said an expert.
  • Obesity Week 2020 In Those With Obesity, Will Losing Weight Cut COVID-19 Severity? Patients with obesity are at high risk and should be treated similarly to the elderly or immunocompromised if they get COVID-19. But if they can lose weight, could they reduce their risk?
  • Obesity Week 2020 Major Breakthrough in Weight Loss With Semaglutide? The larger weight losses (over 20% in 36% of patients) will mean that more patients with obesity will be able to achieve a weight loss they are satisfied with, says the lead of a phase 3 trial.

Conference News

Popular News from Obesity Week 2019

Medscape Diabetes© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.